Item 5: KPMG, Berlin, is proposed as auditor for the current financial year. KPMG has audited the Company since the financial year 2011. Ratio of non-audit/audit fees was 71.40% during the year under review and 64.70% over a three-year aggregate period which exceeds our guidelines. We therefore recommend opposing the proposal.
Item 6: The Company shall be authorised until 19 April 2022 to increase the share capital by up to EUR 77m (~15% of the share capital) by issuing shares against contributions in cash. The total shares issued while disapplying preemptive rights under the proposed authorisation may reach up to 15% of the share capital which exceeds our guidelines according to which we accept a maximum potential dilution of 10%. We recommend opposition.